Co-signaling molecules of the B7-CD28 family in positive and negative regulation of T lymphocyte responses

Microbes and Infection

Volumn 6, Issue 8, 2004, Pages 759-766

  Wang, Shengdian ^a   Chen, Lieping ^a  

^a MAYO CLINIC CANCER CENTER   (United States)

Author keywords

B7; CD28; Costimulation; T cell activation

Indexed keywords

B7 ANTIGEN; CD28 ANTIGEN; CD86 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; IMMUNOGLOBULIN G; LIGAND;

ANTIGEN EXPRESSION; ANTIGEN FUNCTION; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CELL PROLIFERATION; CELL SURVIVAL; CELLULAR IMMUNITY; COLITIS; CYTOKINE PRODUCTION; DENDRITIC CELL; GENE EXPRESSION; GENE IDENTIFICATION; HUMAN; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; IMMUNOLOGICAL TOLERANCE; IMMUNOREACTIVITY; IMMUNOREGULATION; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; TISSUE INJURY; TUMOR CELL; WASTING SYNDROME;

EID: 2942674463     PISSN: 12864579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.micinf.2004.03.007     Document Type: Short Survey

References (44)

1. Carreno B.M., Collins M. The B7 family of ligands and its receptors: new pathways for costimulation and inhibition of immune response. Annu. Rev. Immunol. 20:2002;29-53
2. Sharpe A.H., Freeman G.J. The B7-CD28 superfamily. Nat. Rev. Immunol. 2:2002;116-126
3. Dong H., Zhu G., Tamada K., Chen L. B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion. Nat. Med. 5:1999;1365-1369
4. Freeman G.L., Long A.L., Iwai Y., Bourque K., Chernova T., Nishmura H., Fitz L.J., Malenkovich N., Okazaki T., Byrne M.C., Horton H.F., Fouser L., Carter L., Ling V., Bowman M.R., Carreno B.M., Collins M., Wood C.R., Honjo T. Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation. J. Exp. Med. 192:2000;1027-1034
5. Tseng S.Y., Otsuji M., Gorski K., Huang X., Slansky J.E., Pai S.I., Shalabi A., Shin T., Pardoll D.M., Tsuchiya H. B7-DC, a new dentritic cell molecule with potent costimulatory properties for T cells. J. Exp. Med. 193:2001;839-846
6. Latchman Y., Wood C.R., Chernove T., Chaudhary D., Brown M., Nunes R., Greenfied E.A., Bourque K., Boussiotis V.A., Carter L.L., Carreno B.M., Malenkovich N., Nishimura H., Honjo T., Sharpe A.H., Freeman G.J. PD-L2, a novel B7 homologue, is a second ligand for PD-1 and inhibits T cell activation. Nat. Immunol. 2:2001;261-268
7. Wang S., Bajorath J., Files D.B., Dong H., Jonjo T., Chen L. Molecular modeling and functional mapping of B7-H1 and B7-DC delineate independent binding structures for PD-1 and a costimulatory receptor. J. Exp. Med. 197:2003;1083-1091
8. Wang S., Zhu G., Chapoval A.I., Dong H., Tamada K., Ni J., Chen L. Costimulation of T cells by B7-H2, a B7-like molecule that binds ICOS. Blood. 96:2000;2808-2813
9. Hutloff A., Dittrich A.M., Beier K.C., Eljaschewitsch B., Kraft R., Anagnostopoulos I., Kroczek R.A. ICOS is an inducible T-cell co-stimulator structurally and functionally related to CD28. Nature. 397:1999;263-266
10. Chapoval A.I., Ni J., Lau J.S., Wilcox R.A., Flies D.B., Liu D., Dong H., Sica G.L., Zhu G., Tamada K., Chen L. B7-H3: a costimulatory molecule for T cell activation and IFN-gamma production. Nat. Immunol. 2:2001;269-274
11. Sica G.L., Choi I.N., Zhu G., Tamada K., Wang S., Tamura H., Chapoval A.I., Flies D.B., Bajorath J., Chen L. B7-H4, a molecule of the B7 family, negatively regulates T cell immunity. Immunity. 18:2003;849-861
12. Prasad D.V.R., Richards S., Mai X.M., Dong C. B7S1, a novel B7 family member that negatively regulates T cell activation. Immunity. 18:2003;863-873
13. Zang X., Loke P., Kim J., Murphy K., Waitz R., Allison J.P. B7x: a widely expressed B7 family member that inhibits T cell activation. Proc. Natl. Acad. Sci. USA. 100:2003;10388-10392
14. Watanabe N., Gavrieli M., Sedy J.R., Yang J., Fallarino F., Loftin S.K., Hurchla M.A., Zimmerman N., Sim J., Zang X., Murphy T.L., Russell J.H., Allison J.P., Murphy F.M. BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1. Nat. Immunol. 4:2003;630-638
15. Schwartz J.C., Zhang X., Federov A.A., Nathenson S.G., Almo S.C. Structural basis for co-stimulation by the human CTLA-4/B7-2 complex. Nature. 410:2001;604-608
16. Stamper C.C., Zhang Y., Tobin J.F., Erbe D.V., Ikemizu S., Davis S.J., Stahl M.L., Seehra J., Somers W.S. Crystal structure of the B7-1/CTLA-4 complex that inhibits human immune responses. Nature. 410:2001;608-611
17. Wang S., Zhu G., Tamada K., Chen L., Bajorath J. Ligand binding sites of inducible costimulator and high avidity mutants with improved function. J. Exp. Med. 195:2002;1033-1041
18. Phan G.Q., Yang J.C., Sherry R.M., Hwu P., Topalian S.L., Schwartzentruber D.J., Restifo N.P., Haworth L.R., Seipp C.A., Freezer L.J., Morton K.E., Mavroukalis S.A., Duray P.H., Steinberg S.M., Allison J.P., Davis T.A., Rosengerg S.A. Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma. Proc. Natl. Acad. Sci. USA. 100:2003;8372-8377
19. Grohmann U., Orabona C., Fallarino F., Vacca C., Calcinaro F., Falomi A., Candeloro P., Belladonna M.L., Bianchi R., Fioretti M.C., Puccetti P. CTLA-4-Ig regulates tryptophan catabolism in vivo. Nat. Immunol. 3:2003;1097-1101
20. Fallarino F., Grohmann U., Hwang K.W., Orabona C., Vacca C., Bianchi R., Belladonna M.L., Fioretti M.C., Alegre M.L., Puccetti P. Modulation of tryptophan catabolism by regulatory T cells. Nat. Immunol. 4:2003;1206-1212
21. Salomon B., Lenschow D.J., Rhee L., Ashourian N., Singh B., Sharpe A.H., Bluestone J.A. B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes. Immunity. 12:2000;431-440
22. Lohr J., Knoechel B., Jiang S., Sharpe A.H., Abbas A.K. The inhibitory function of B7 costimulators in T cell responses to foreign and self-antigens. Nat. Immunol. 4:2003;664-669
23. Tamura H., Dong H., Zhu G., Sica G.L., Flies D.B., Tamada K., Chen L. B7-H1 costimulation preferentially enhances CD28-independent T-help cell function. Blood. 97:2001;1809-1816
24. Dong H., Strome S.E., Salomao D.R., Tamura H., Hirano F., Flies D.B., Roche P.C., Lu J., Zhu G., Tamada K., Lennon V.A., Celis E., Chen L. Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion. Nat. Med. 8:2002;793-800
25. Shin T., Kennedy G., Gorski K., Tsuchiya H., Koseki H., Azuma M., Yagita H., Chen L., Powell J., Pardoll D., Housseau F. Cooperative B7-1/2 (CD80/CD86) and B7-DC costimulation of CD4+ T cells independent of the PD-1 receptor. J. Exp. Med. 198:2003;31-38
26. Curiel T.J., Wei S., Dong H., Alvarez X., Cheng P., Mottram P., Kizysiek R., Knutson K.L., Daniel B., Zimmermann M.C., David O., Burow M., Gordon A., Dhurandhar N., Myers L., Berggern R., Hemminki A., Alvarez R.D., Emilie D., Curiel D.T., Chen L., Zou W. Block of B7-H1 improves myeloid dendritic cell-mediated antitumor immunity. Nat. Med. 9:2003;562-567
27. Iwai Y., Ishida M., Tanaka Y., Okazaki T., Honjo T., Minato N. Involvement of PD-L1 cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade. Proc. Natl. Acad. Sci. USA. 99:2002;12293-12297
28. Liu X., Gao J.X., Wen J., Yin L., Li O., Zuo T., Gajewski T.F., Fu Y.X., Zheng P., Liu Y. B7DC/PDL2 promotes tumor immunity by a PD-1-independent mechanism. J. Exp. Med. 197:2003;1721-1730
29. Kanai T., Totsuka T., Uraushihara K., Makita S., Nakamura T., Koganei K., Fukushima T., Akiba H., Yagita H., Okumura K., Machida U., Iwai H., Azuma M., Chen L., Watanabe M. Blockade of B7-H1 suppresses the development of chronic intestinal inflammation. J. Immunol. 171:2003;4156-4163
30. Tsushima F., Iwai H., Otsuki N., Abe M., Hirose S., Yamazaki T., Akiba H., Yagita H., Yakahashi Y., Omura K., Okumura K., Azuma M. Preferential contribution of B7-H1 to programmed death-1-mediated regulation of hapten-specific allergic inflammatory responses. Eur. J. Immunol. 33:2003;2773-2782
31. Yoshinaga S.K., Whoriskey J.S., Khare S.D., Sarmiento U., Guo J., Horan T., Shih G., Zhang M., Coccia M.A., Kohno T., Tafuri-Bladt A., Brankow D., Campbell P., Chang D., Chiu L., Dai T., Duncan G., Elliott G.S., Hui A., McCabe S.M., Scully S., Shahinian A., Shaklee C.L., Van G., Mak T.W., Senaldi G. T-cell co-stimulation through B7RP-1 and ICOS. Nature. 402:1999;827-832
32. Coyle A.J., Lehar S., Lloyd C., Tian J., Delaney T., Manning S., Nguyen T., Burwell T., Schneider H., Gonzalo J.A., Gosselin M., Owen L.R., Rudd C.E., Gutierrez-Ramos J.C. The CD28-related molecule ICOS is required for effective T cell-dependent immune responses. Immunity. 13:2000;95-105
33. Mak T.W., Shahinian A., Yoshinaga S.K., Wakeham A., Boucher L.M., Pintilie M., Duncan G., Gajewska B.U., Gronski M., Eriksson U., Odermatt B., Ho A., Bouchard D., Whorisky J.S., Jordana M., Ohashi P.S., Pawson T., Bladt F., Tafuri A. Costimulation through the inducible costimulator ligand is essential for both T helper and B cell functions in T cell-dependent B cell responses. Nat. Immunol. 4:2003;765-772
34. Tafuri A., Shahinian A., Bladt F., Yoshinaga S.K., Jordana M., Wakeham A., Boucher L.M., Bouchard D., Chan V.S., Duncan G., Odermatt B., Ho A., Itie A., Horan T., Whoriskey J.S., Pawson T., Penninger J.M., Ohashi P.S., Mak T.W. ICOS is essential for effective T-helper-cell responses. Nature. 409:2001;105-109
35. Lohning M., Hutloff A., Kallinich T., Mages H.W., Bonhagen K., Radbruch A., Hamelmann E., Kroczek R.A. Expression of ICOS in vivo defines CD4+ effector T cells with high inflammatory potential and a strong bias for secretion of interleukin 10. J. Exp. Med. 197:2003;181-193
36. Khayyamian S., Hutloff A., Buchner K., Grafe M., Henn V., Kroczek R.A., Mages H.W. ICOS-ligand, expressed on human endothelial cells, costimulates Th1 and Th2 cytokine secretion by memory CD4+ T cells. Proc. Natl. Acad. Sci. USA. 99:2002;6198-6203
37. Grimbacher B., Hutloff A., Schlesier M., Glocker E., Warnatz K., Drager R., Eibel H., Fischer B., Schaffer A.A., Mages H.W., Kroczek R.A., Peter H.H. Homozygous loss of ICOS is associated with adult-onset common variable immunodeficiency. Nat. Immunol. 4:2003;261-268
38. Wallin J.J., Liang L., Bakardjiev A., Sha W.C. Enhancement of CD8+ T cell responses by ICOS/B7h costimulation. J. Immunol. 167:2001;132-139
39. Sun M., Richards S., Prasad D.V., Mai X.M., Rudensky A., Dong C. Characterization of mouse and human B7-H3 genes. J. Immunol. 168:2002;6294-6297
40. Ling V., Wu P.W., Spaulding V., Kieleczawa J., Luxenberg D., Carreno B.M., Collins M. Duplication of primate and rodent B7-H3 immunoglobulin V- and C-like domains: divergent history of functional redundancy and exon loss. Genomics. 82:2003;365-377
41. Steinberger P., Majdic O., Derdak S.V., Pfistershammer K., Kirchberger S., Klauser C., Zlabinger G., Pickl W.F., Stöckl J., Knapp W. Molecular characterization of human 4Ig-B7-H3, a member of the B7 family with four Ig-like domains. J. Immunol. 172:2004;2352-2359
42. Sun X., Vale M., Leung E., Kanwar J.R., Gupta R., Krissansen G.W. Mouse B7-H3 induces antitumor immunity. Gene Ther. 10:2003;1728-1734
43. Suh W.K., Gajewska B.U., Okada H., Gronski M.A., Bertram E.M., Dawicki W., Duncan G.S., Bukczynski J., Plyte S., Elia A., Wakeham A., Itie A., Chung S., Da Costa J., Arya S., Horan T., Campbell P., Gaida K., Ohashi P.S., Watts T.H., Yoshinaga S.K., Bray M.R., Jordana M., Mak T.W. The B7 family member B7-H3 preferentially down-regulates T helper type 1-mediated immune responses. Nat. Immunol. 4:2003;899-906
44. Choi I.H., Zhu G., Sica G.L., Strome S.E., Cheville J.C., Lau J.S., Zhu Y., Flies D.B., Tamada K., Chen L. Genomic organization and expression analysis of B7-H4, an immune inhibitory molecule of the B7 family. J. Immunol. 171:2003;4650-4654